We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Fresh Whole Blood Reduces Transfusion-Related Illnesses for Pediatric Heart Surgery

By LabMedica International staff writers
Posted on 11 May 2015
The use of fresh whole blood from single donors may reduce the risk of lifelong complications for young children undergoing heart surgery.

At present, component blood consisting of blood parts such as red blood cells, platelets or plasma from multiple donors tends to be the standard form of blood used for transfusion among children undergoing heart surgery, but the use of component blood exposes children to multiple donors, and raises their risk of transfusion-related complications. More...


Critical care physicians at The Children's Hospital of Philadelphia (Philadelphia, PA, USA) assessed the blood bank records and surgical registry data from 1995 to 2010 of 4,111 pediatric patients with an average age of 94 days. Of these patients, 3,836 received fresh whole blood, while 252 received blood components due to the unavailability of fresh whole blood. Blood was obtained from daily donations 24 to 48 hours before operation, underwent standard labeling and testing for transmissible disease, was stored at 4 °C, and was delivered to the hospital the evening before operation.

The investigators found that the youngest patients whose heart procedures were complex were exposed to the highest number of blood donors, while older patients who underwent simpler heart procedures were exposed to the fewest number of blood donors. On comparing the number of blood donor exposures among children in the program with those detailed in published reports of component blood use, they found that overall the use of fresh whole blood was associated with a lower number of donor exposures. This indicated that the use of fresh whole blood can lower the risk of transfusion-related illnesses among pediatric heart surgery patients.

The authors concluded that most young patients undergoing complex surgical procedures will continue to require multiple transfusions. For those patients, they believe that their experience with the use of fresh whole blood demonstrates a consistent reduction in donor exposure compared with the exclusive use of components and potentially reduces the risks of transfusion. Their experience also demonstrates that the provision of fresh whole blood, although logistically complicated and dependent on cooperation and careful communication, is feasible as a sustainable operating protocol between a blood center, a blood bank and the pediatric cardiothoracic surgery service they support. The study was published on March 25, 2015, in the journal the Annals of Thoracic Surgery.

Related Links:

The Children's Hospital of Philadelphia 



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Electrolyte Analyzer
BKE-B
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The test combines RNA signals from the tumor-immune microenvironment to predict treatment response, rather than relying on a single marker such as PD-L1 expression.(Image Credit: Adobe Stock)

RNA-Based Test Predicts Immunotherapy Response in Non-Small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) represents the largest U.S. patient population eligible for immune checkpoint inhibitor therapy. Treatment selection often relies on PD-L1 expression, but a single protein... Read more

Immunology

view channel
Image Credit: Adobe Stock

Immune Profiling Identifies Early Maternal Autoantibodies Linked to Preterm Birth Risk

A typical pregnancy lasts about 40 weeks, but labor begins prematurely in roughly one in 10 pregnancies. Preterm birth is the leading cause of newborn death worldwide, yet its underlying causes and which... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: NeoGenomics selected Indica Labs’ HALO AP platform to eable its digital pathology operations through a scalable, cloud-based framework (Photo courtesy of Indica Labs)

Expanded Partnership Scales AI-Powered Digital Pathology for Oncology

Oncology diagnostics rely on pathology and biomarker information to guide personalized treatment. As computational pathology and artificial intelligence (AI) expand insights from tissue analysis, laboratories... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.